Gerry Brunk

Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA.

Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA.

BAROnova, Inc. operates as a clinical-stage medical-device company. It develops nonsurgical, nonpharmacologic devices. The firm's TransPyloric Shuttle device enables the patient' stomach to fill up faster, stay full longer, and potentially delay gastric emptying. The company was founded by Hugh Narciso in 2006 and is headquartered in Goleta, CA.

Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.

Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA.

Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL.

Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ.

HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI.

Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation.

LAVA Medtech Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on March 31, 2021 and is headquartered in Waltham, MA.

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019.